Fundraising FoxReactive Biosciences
2 known investors
Find your way into Reactive Biosciences
Sign up to see every warm intro you have to Reactive Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Reactive Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reactive Biosciences is a drug discovery company applying a boron-based chemistry platform to develop new medicines.
Also known as Reactive Bioscience · reactivebio.com
Investors · 2
Company profile
researched Aug 2026Reactive Biosciences is a biotechnology company that uses a boron-based discovery platform to identify and develop new medicines, as described in the portfolio listing of its investor Pappas Capital. The investor description characterizes the platform as the world's leading boron-based discovery platform and frames the company's work as discovering and developing medicines in new ways.
The available material does not describe specific therapeutic programs, pipeline stage, headquarters location, founding date, team, or financial details. The company is listed under Pappas Capital's ventures portfolio and maintains a web presence at reactivebio.com; the record under review also associates the company with the domain boragenbio.com.
▸Full profile — market position, technology
Market position
The company is presented by its investor as operating a boron-based discovery platform described as the world's leading platform of its kind. No independent market share, competitive, or benchmarking data appears in the available sources.
Technology
According to its investor's portfolio page, the company's core technology is a boron-based discovery platform used for medicine discovery and development. No further technical detail, such as target classes, chemistry methods, or specific compounds, is provided in the available sources.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 3
primary sources listed
- Reactive Biosciences - Pappas Capitalpappas-capital.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Reactive Biosciences do?
- Reactive Biosciences is a drug discovery company applying a boron-based chemistry platform to develop new medicines.
- Who are Reactive Biosciences's investors?
- Reactive Biosciences's investors include ARCH Venture Partners, Canaan Partners.